Up a level |
Sirijatuphat, Rujipas, Manosuthi, Weerawat, Niyomnaitham, Suvimol, Owen, Andrew ORCID: 0000-0002-9819-7651, Copeland, Katherine Kradangna, Charoenpong, Lantharita, Rattanasompattikul, Manoch, Mahasirimongkol, Surakameth, Wichukchinda, Nuanjun and Chokephaibulkit, Kulkanya
(2022)
Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study.
EMERGING MICROBES & INFECTIONS, 11 (1).
pp. 2197-2206.
Manolio, Teri A, Hutter, Carolyn M, Avigan, Mark, Cibotti, Ricardo, Davis, Robert L, Denny, Joshua C, La Grenade, Lois, Wheatley, Lisa M, Carrington, Mary N, Chantratita, Wasun et al (show 20 more authors)
(2018)
Research Directions in Genetic Predispositions to Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 103 (3).
pp. 390-394.
Maverakis, Emanual, Wang, Elizabeth A, Shinkai, Kanade, Mahasirimongkol, Surakameth, Margolis, David J, Avigan, Mark, Chung, Wen-Hung, Goldman, Jennifer, La Grenade, Lois, Pirmohamed, Munir ORCID: 0000-0002-7534-7266 et al (show 13 more authors)
(2017)
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines Results of a National Institutes of Health Working Group.
JAMA DERMATOLOGY, 153 (6).
pp. 587-592.